Primary care COPD code and inhaled medication pre- and post-Lung Health Check visit
| Seen by CRT (or GP) excluding normal spiro | CRT/GP spirometry showed no obstruction | Declined referral/failed to respond | Not invited/not seen for other reasons | All excluding CRT/GP normal spiro | ||||||
| Number of participants, % of overall eligible cohort | 85 | 42% | 20 | 10% | 46 | 23% | 50 | 25% | 181 | 90% |
| Number without access to primary care record | 5 | 0 | 4 | 4 | 13 | |||||
| Number with access to primary care record | 80 | 20 | 42 | 46 | 168 | |||||
| GP COPD code, n, % of those with visible record | 46 | 58% | 7 | 35% | 7 | 17% | 6 | 13% | 59 | 35% |
| Inhalers prior to LHC (% those with visible record) | ||||||||||
| SABA (ceased in parentheses), n, % | 16 (4) | 20% (5%) | 4 (2) | 20% (10%) | 5 (9) | 12% (21%) | 6 (5) | 13% (11%) | 27 (18) | 16% (11%) |
| LAMA/LABA (ceased in parentheses), n, % | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) | 1 (0) | 2% (0%) | 1 (0) | 1% (0%) |
| ICS/LAMA/LABA (ceased in parentheses), n, % | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) |
| ICS/LABA (ceased in parentheses), n, % | 1 (1) | 1% (1%) | 0 (0) | 0% (0%) | 0 (1) | 0% (2%) | 2 (0) | 4% (0%) | 3 (2) | 2% (1%) |
| ICS (ceased in parentheses), n, % | 0 (1) | 0% (1%) | 0 (0) | 0% (0%) | 0 (1) | 0% (2%) | 1 (2) | 2% (4%) | 1 (4) | 1% (2%) |
| Any inhaled medication, n, % | 16 | 20% | 4 | 20% | 5 | 12% | 6 | 13% | 27 | 16% |
| New inhalers since LHC (% those with visible record) | ||||||||||
| SABA (ceased in parentheses), n, % | 26 (0) | 33% (0%) | 5 (0) | 25% (0%) | 4 (0) | 10% (0%) | 6 (0) | 13% (0%) | 36 (0) | 21% (0%) |
| LAMA/LABA (ceased in parentheses), n, % | 28 (1) | 35% (1%) | 4 (0) | 20% (0%) | 8 (1) | 19% (2%) | 6 (0) | 13% (0%) | 42 (2) | 25% (1%) |
| ICS/LAMA/LABA (ceased in parentheses), n, % | 1 (1) | 1% (1%) | 1 (0) | 5% (0%) | 0 (0) | 0% (0%) | 1 (0) | 2% (0%) | 2 (1) | 1% (1%) |
| ICS/LABA (ceased in parentheses), n, % | 2 (0) | 3% (0%) | 1 (0) | 5% (0%) | 0 (1) | 0% (2%) | 1 (0) | 2% (0%) | 3 (1) | 2% (1%) |
| ICS (ceased in parentheses), n, % | 0 (0) | 0% (0%) | 1 (0) | 5% (0%) | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) | 0 (0) | 0% (0%) |
| Any inhaled medication, n, % | 38 | 48% | 9 | 45% | 9 | 21% | 9 | 20% | 56 | 33% |
CRT, community respiratory team; ICS, inhaled corticosteroid; LABA, long acting beta agonist; LAMA, long acting muscarinic antagonist; LHC, Lung Health Check; SABA, short acting beta agonist.